Experience

D3 Bio Completes $62 Million Series A+

April 15, 2024

Cooley advised D3 Bio – an emerging global biotechnology company that focuses on discovery, development and registration of innovative cancer drugs – on the close of its $62 million Series A+ financing.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Andrew Harline
Partner in Charge – Singapore, Singapore
Lunga Su
Associate, Shanghai
Xander Lee
Partner, Los Angeles Santa Monica
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Zack Gong
Associate, Shanghai
Qi Wang
Associate, Beijing
Kaiting Yang
Associate, Hong Kong
Sherlyn Qu
Legal Consultant, Shanghai
Teresa Yang
Legal Consultant, Shanghai
Cindy Pan
International Legal Project Manager, Hong Kong

Related Practices & Industries

ProfoundBio Announces $112 Million Oversubscribed Series B

February 14, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its $112 million oversubscribed Series B financing.

Read more

Related contacts

Patrick Loofbourrow
Partner, Singapore
Monica Xu
Counsel, Shanghai
Ivy Wang
Associate, Shanghai
Zixiang Liu
Associate, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai
Xander Lee
Partner, Los Angeles Santa Monica
Charlie Kim
Partner, San Diego
Christopher Kimball
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Letian Wei
Legal Consultant, Shanghai
Teresa Yang
Legal Consultant, Shanghai

Related Practices & Industries

2023 05 11 NeuExcell Therapeutics Announces 15 Million Series Pre-A

NeuExcell Therapeutics Announces $15 Million Series Pre-A+

May 15, 2023

Cooley advised NeuExcell Therapeutics, a neurodegenerative disease gene therapy company, on its $15 million+ Series Pre-A+ financing round.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Lunga Su
Associate, Shanghai
Teresa Yang
Legal Consultant, Shanghai

Related Practices & Industries

SJ Semiconductor Signs $340 Million Series C+ Financing

April 12, 2023

Cooley advised SJ Semiconductor Corporation (SJSemi), a semiconductor foundry, on its $340 million Series C+ financing, with a post-money valuation of close to US$2 billion.

Related contacts

Ruomu Li
Partner, Shanghai
Wenlan Geng
Associate, Shanghai
Teresa Yang
Legal Consultant, Shanghai
Zixiang Liu
Associate, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai

Related Practices & Industries